doi: 10.1055/s-0042-109065 Summary Keywords diabetes mellitus type 2, cardiovascular disease, cardiovascular risk, diabetic kidney disease, sodium-glucose cotransporter-2 inhibitor, glucagon-like peptide-1 receptor agonist, aldosterone, renin Citation Puglisi S, Rossini A, Poli R, Dughera F, Pia A, Terzolo M and Reimondo G (2021) Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System
Zhao LH, Ma S, Sutkeviciute I, Shen DD, Zhou XE, de Waal PW, et al
had some aluminium foil or something inside
A 50-unit syringe holds 0.5 mL total
Sample size and statistical analysis A total sample size of 98 participants is estimated to provide 80% power to detect a 3% difference in weight change between groups, accounting for a 10% loss to follow-up
Each pen delivers its labeled dose in a fixed volume that you cannot adjust